Christopher T. Stow-Serge joined Odom & Des Roches in 2016, after serving as a judicial clerk and working in private practice at a large litigation firm. With Odom & Des Roches, Christopher has been actively involved in the firm’s complex litigation and antitrust litigation practices, including the following representative cases:
King Drug, et al. v. Cephalon, et al. (Provigil), (brought case to trial) (settlements totaling more than $760,000,000)
Abshire, et al. v. State of Louisiana, et al., No. 377713 c/w 412265 (La. 24thJ.D.C.) (settled for $5,810,000)
In re: Namenda Direct Purchaser Antitrust Litigation, 15-7488 (S.D. N.Y.) (ongoing)
In re: Niaspan Antitrust Litigation, MDL No. 2460 (E.D. Pa.) (ongoing)
In re: Lamictal Direct Purchaser Antitrust Litigation, No. 12-995 (D. N.J.) (ongoing)
In re: Opana ER Antitrust Litigation, MDL No. 2580 (N.D. Ill.) (ongoing)
Christopher earned his undergraduate and juris doctor degrees at Tulane University, where he was selected for the Order of the Coif. He is admitted to practice before the state courts of Louisiana, as well as the U.S. District Court for the Eastern District of Louisiana, the U.S. District Court for the Western District of Louisiana, and the U.S. Fifth Circuit Court of Appeals.